Agenus, Inc. (AGEN)
6.73
-0.14
(-2.04%)
USD |
NASDAQ |
Nov 13, 16:00
6.72
-0.01
(-0.15%)
After-Hours: 19:59
Agenus Price : 6.73 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 6.97 | 6.97 | 6.50 | 6.73 | 465153.0 |
| Nov 12, 2026 | 7.07 | 7.085 | 6.775 | 6.87 | 499052.0 |
| Nov 11, 2026 | 7.13 | 7.29 | 7.02 | 7.22 | 430505.0 |
| Nov 10, 2026 | 7.10 | 7.13 | 6.635 | 7.02 | 691628.0 |
| Nov 09, 2026 | 7.32 | 7.65 | 7.11 | 7.15 | 840872.0 |
| Nov 06, 2026 | 6.54 | 7.20 | 6.372 | 7.15 | 873557.0 |
| Nov 05, 2026 | 6.81 | 6.93 | 6.11 | 6.44 | 1.335M |
| Nov 04, 2026 | 6.99 | 7.06 | 6.85 | 6.97 | 729963.0 |
| Nov 03, 2026 | 6.59 | 6.86 | 6.500 | 6.67 | 499036.0 |
| Nov 02, 2026 | 6.85 | 6.855 | 6.43 | 6.53 | 595555.0 |
| Oct 30, 2026 | 6.87 | 7.09 | 6.69 | 6.84 | 564493.0 |
| Oct 29, 2026 | 7.13 | 7.30 | 6.942 | 7.09 | 625387.0 |
| Oct 28, 2026 | 6.51 | 7.14 | 6.47 | 7.13 | 744298.0 |
| Oct 27, 2026 | 6.13 | 6.675 | 6.11 | 6.65 | 839018.0 |
| Oct 26, 2026 | 6.49 | 6.50 | 6.14 | 6.16 | 687894.0 |
| Oct 23, 2026 | 6.36 | 6.50 | 6.16 | 6.33 | 510514.0 |
| Oct 22, 2026 | 6.32 | 6.53 | 6.236 | 6.51 | 553954.0 |
| Oct 21, 2026 | 6.43 | 6.54 | 6.31 | 6.40 | 789683.0 |
| Oct 20, 2026 | 6.10 | 6.58 | 6.05 | 6.42 | 827183.0 |
| Oct 19, 2026 | 6.13 | 6.30 | 6.055 | 6.18 | 734956.0 |
| Oct 16, 2026 | 6.65 | 6.70 | 6.00 | 6.04 | 1.029M |
| Oct 15, 2026 | 6.52 | 6.99 | 6.51 | 6.68 | 815431.0 |
| Oct 14, 2026 | 6.88 | 7.14 | 6.46 | 6.50 | 980140.0 |
| Oct 13, 2026 | 7.30 | 7.34 | 6.805 | 6.95 | 995561.0 |
| Oct 12, 2026 | 7.625 | 7.66 | 7.39 | 7.43 | 572490.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Halozyme Therapeutics, Inc. | 100.27 |
| AVITA Medical, Inc. | 15.63 |
| Iovance Biotherapeutics, Inc. | 7.76 |
| Xencor, Inc. | 37.09 |
| Amgen, Inc. | 465.67 |
Price Related Metrics
| PE Ratio | 9.271 |
| PS Ratio | 2.490 |
| Earnings Yield | 10.79% |
| Market Cap | 304.25M |
| Operating PE Ratio | 6.394 |
| Normalized PE Ratio | 5.543 |